[
  {
    "ts": null,
    "headline": "Is Regeneron Pharmaceuticals, Inc. (REGN) a Promising Biotech Stock According to Wall Street Analysts",
    "summary": "We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The biotechnology sector is gaining new momentum with better market […]",
    "url": "https://finnhub.io/api/news?id=73c118e6969f253b0b221bee4a8034fc66ab752e7b44ce0f0643d4fae76ce268",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742938731,
      "headline": "Is Regeneron Pharmaceuticals, Inc. (REGN) a Promising Biotech Stock According to Wall Street Analysts",
      "id": 133445019,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The biotechnology sector is gaining new momentum with better market […]",
      "url": "https://finnhub.io/api/news?id=73c118e6969f253b0b221bee4a8034fc66ab752e7b44ce0f0643d4fae76ce268"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025",
    "summary": "TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the ’Investors and Media’ page of Regeneron’s websi",
    "url": "https://finnhub.io/api/news?id=b11a1109ff6abf211a7a5e169ed29e7ea079e7aff3293f9d52f1459eec974953",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742933100,
      "headline": "Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025",
      "id": 133445020,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the ’Investors and Media’ page of Regeneron’s websi",
      "url": "https://finnhub.io/api/news?id=b11a1109ff6abf211a7a5e169ed29e7ea079e7aff3293f9d52f1459eec974953"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b84b411036bdf810bf6f9864078d3897c9864f3f1f6e42eb5c1c2008c5ca9747",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742920200,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
      "id": 133455077,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b84b411036bdf810bf6f9864078d3897c9864f3f1f6e42eb5c1c2008c5ca9747"
    }
  },
  {
    "ts": null,
    "headline": "UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study",
    "summary": "UNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical significance for the primary goal.",
    "url": "https://finnhub.io/api/news?id=39aea18a7fc473fc05e18de79b0970a18e3baf109fe88bcce6bbc1ca648b2580",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742917860,
      "headline": "UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study",
      "id": 133445021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "UNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical significance for the primary goal.",
      "url": "https://finnhub.io/api/news?id=39aea18a7fc473fc05e18de79b0970a18e3baf109fe88bcce6bbc1ca648b2580"
    }
  },
  {
    "ts": null,
    "headline": "Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst?",
    "summary": "We recently published a list of 11 Best Extremely Profitable Stocks to Buy According to Analysts. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other best extremely profitable stocks to buy according to analysts. Fed’s Response to Inflation and Growth Challenges We recently covered 10 Best […]",
    "url": "https://finnhub.io/api/news?id=38d14c0f7eba7c6c7a33ae74d5aedf9c9980a4a8f9e9d6d13200c14b19aa2729",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742909863,
      "headline": "Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst?",
      "id": 133375749,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently published a list of 11 Best Extremely Profitable Stocks to Buy According to Analysts. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other best extremely profitable stocks to buy according to analysts. Fed’s Response to Inflation and Growth Challenges We recently covered 10 Best […]",
      "url": "https://finnhub.io/api/news?id=38d14c0f7eba7c6c7a33ae74d5aedf9c9980a4a8f9e9d6d13200c14b19aa2729"
    }
  }
]